KEY FINDINGS
The global cystic fibrosis therapeutics market is anticipated to grow at a rate of 10.04% during the estimated period of 2020-2028. A rise in incidences of cystic fibrosis across the globe, an increase in medications against cystic fibrosis, and a hike in R&D investments towards the development of drugs to treat cystic fibrosis are boosting the market.
MARKET INSIGHTS
Cystic fibrosis is a disease that is inherited and mainly affects the lungs and other body parts like the kidney, pancreas, and liver. In cystic fibrosis, thick and sticky mucus is produced by the body that may block the lungs and obstruct the pancreas. There is no cure for the fatal disease, but taking proper medication and nutrition to reduce excess mucus produced in the lungs and kidney can help in increasing the patient's lifespan. The disease is most prevalent in newborns, and has led the researchers towards the development of advanced therapeutics, which may increase the life span of the patients. However, the high costs involved in cystic fibrosis treatment and the introduction of generic drugs impede the market growth. At the same time, the growth of the healthcare industry in developing economies is expected to create profitable opportunities in the future.
REGIONAL INSIGHTS
The global cystic fibrosis therapeutics market is geographically analyzed based on markets situated in North America, Europe, Asia Pacific, and the Rest of the World. As of 2019, the region of Europe holds the largest market share in terms of revenue, and continues the trend by the end of the forecast period. This is attributed to the presence of key players investing largely in the development of new technologies. The market region of Europe is predicted to be the fastest-growing market in terms of revenue. The major factor driving the growth is the surge in incidences of cystic fibrosis in the region.
COMPETITIVE INSIGHTS
Abbott Laboratories, GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd, Pharmaxis Ltd, Novartis International AG, etc. are some of the leading companies registering their presence in the global market.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Global Cystic Fibrosis Therapeutics Market Forecast 2020-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Advancements In The Cystic Fibrosis Therapeutics Treatment
3.2.2. Increasing Incidence Of Cystic Fibrosis (Cf)
3.2.3. Rise In The R&D Of Novel Cystic Fibrosis Therapeutics
3.3. Key Restraints
3.3.1. Stringent Regulation
3.3.2. Low Awareness Among Developing Economies
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Pestel Analysis
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights
5. Market By Route Of Administration
5.1. Inhale
5.2. Oral
6. Market By Drug Class
6.1. Cftr Modulators
6.2. Bronchodilators
6.3. Mucolytic
6.4. Pancreatic Enzyme Supplements
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Australia & New Zealand
7.3.5. South Korea
7.3.6. Thailand
7.3.7. Indonesia
7.3.8. Vietnam
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East & Africa
8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Agilent Technologies Inc
8.4. Allergan Plc
8.5. F. Hoffmann-La Roche
8.6. Gilead Sciences Inc
8.7. Glaxosmithkline Plc
8.8. Johnson & Johnson
8.9. Mylan N.V
8.10. Novartis Ag
8.11. Perkinelmer
8.12. Pfizer Inc
8.13. Pharmaxis Ltd
8.14. Teva Pharmaceutical Industries Ltd
8.15. Vertex Pharmaceuticals Incorporated
List of Tables
Table 1: Market Snapshot - Veterinary Vaccine
Table 2: Global Cystic Fibrosis Therapeutics, By Route Of Administration, Historical Years, 2016-2019 (In $ Million)
Table 3: Global Cystic Fibrosis Therapeutics, By Route Of Administration, Forecast Years, 2020-2028 (In $ Million)
Table 4: Global Inhale Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 5: Global Inhale Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 6: Global Oral Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 7: Global Oral Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 8: Global Cystic Fibrosis Therapeutics, By Drug Class, Historical Years, 2016-2019 (In $ Million)
Table 9: Global Cystic Fibrosis Therapeutics, By Drug Class, Forecast Years, 2020-2028 (In $ Million)
Table 10: Global Cftr Modulators Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 11: List Of Cftr Modulators Generic And Brand Name
Table 12: Global Cftr Modulators Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 13: Global Bronchodilators Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 14: List Of Bronchodilators Generic And Brand Name
Table 15: Global Bronchodilators Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 16: Global Mucolytic Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 17: List Of Mucolytics Generic And Brand Name
Table 18: Global Mucolytic Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 19: Global Pancreatic Enzyme Supplements Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 20: Global Pancreatic Enzyme Supplements Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 21: Global Cystic Fibrosis Therapeutics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 22: Global Cystic Fibrosis Therapeutics Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 23: North America Cystic Fibrosis Therapeutics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 24: North America Cystic Fibrosis Therapeutics Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 25: Europe Cystic Fibrosis Therapeutics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 26: Europe Cystic Fibrosis Therapeutics Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 27: Asia Pacific Cystic Fibrosis Therapeutics, By Country, Historical Years, 2016-2019 (In $ Million)
Table 28: Asia Pacific Cystic Fibrosis Therapeutics, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 29: Rest Of World Cystic Fibrosis Therapeutics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 30: Rest Of World Cystic Fibrosis Therapeutics Market, By Region, Forecast Years, 2020-2028 (In $ Million)
List of Figures
Figure 1: Porter's Five Forces Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Cystic Fibrosis Therapeutics, By Route Of Administration, In 2019
Figure 6: Global Cystic Fibrosis Therapeutics Market, By Inhale, 2020-2028 (In $ Million)
Figure 7: Global Cystic Fibrosis Therapeutics Market, By Oral, 2020-2028 (In $ Million)
Figure 8: Global Cystic Fibrosis Therapeutics, By Drug Class, In 2019
Figure 9: Global Cystic Fibrosis Therapeutics Market, By Cftr Modulators, 2020-2028 (In $ Million)
Figure 10: Global Cystic Fibrosis Therapeutics Market, By Bronchodilators, 2020-2028 (In $ Million)
Figure 11: Global Cystic Fibrosis Therapeutics Market, By Mucolytic, 2020-2028 (In $ Million)
Figure 12: Global Cystic Fibrosis Therapeutics Market, By Pancreatic Enzyme Supplements, 2020-2028 (In $ Million)
Figure 13: North America Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 14: The United States Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 15: Canada Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 16: Europe Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 17: The United Kingdom Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 18: France Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 19: Germany Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 20: Italy Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 21: Russia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 22: Belgium Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 23: Poland Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 24: Rest Of Europe Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 25: Asia Pacific Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 26: China Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 27: Japan Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 28: India Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 29: Australia & New Zealand Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 30: South Korea Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 31: Thailand Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 32: Indonesia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 33: Vietnam Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 34: Rest Of Asia Pacific Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 35: Rest Of World Cystic Fibrosis Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 36: Latin America Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 37: Middle East & Africa Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Global Thyroid Gland Disorders Treatment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 80
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period.
The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
Global Enzyme Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 84
According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
Global Hormone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
